Macular edema is a common feature of posterior segment diseases. It is an expression of abnormal permeability in either retinal vessels (inner blood-retinal barrier) or in the retinal pigment epithelium (outer blood-retinal barrier). It occurs in either a diffuse pattern where the macula appears generally thickened or, in more severe cases, as cystoid edema with the typical petaloid appearance. Grid laser treatment may be useful to reduce macular edema. Spots of 100–250 micrometers in diameter are applied to the whole posterior pole, one to two groups apart. The foveal avascular zone remains untouched. In patients treated bilaterally, areas temporal and nasal to the macula must be spared to prevent the development of deep scotomas. The mechanism yielding positive results with the grid technique is still debated. Among the most reliable hypotheses are: Proliferation of pigment epithelial cells, followed by and improved efficiency of the outer blood-retinal barrier; proliferation of endothelial cells in retinal capillaries followed by an improved efficiency of the inner blood-retinal barrier; improvement of the retinochoroidal exchanges, and finally, release by coagulative necrosis of a factor able to improve the efficiency of the blood-retinal barriers. Lasers with long wavelengths, such as krypton red and diode, are the most appropriate ones to perform grid treatment.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Ferris FL III, Patz A. Macular edema. A complication of diabetic retinopathy. Surv Ophthalmol 1984; 29: 452-61.
Cunha-Vaz JG, Travassos A. Breakdown of the blood retinal barrier and cystoid macular edema. Surv Ophthalmol 1984; 29: 465-92.
Goldberg MF. Diseases affecting the inner blood-retinal barrier. In: Cunha-Vaz JG, ed. The blood retinal barriers. New York: Plenum Publishing Corp. 1979.
Jampol LM. Macular edema. In: Ryan SJ, ed. Retina. Vol. 2. St. Louis: CV Mosby, 1989: 83-89.
The Early Treatment of Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema. Arch Ophthalmol 1985; 103: 1796-806.
The Early Treatment of Diabetic Retinopathy Study Research Group. Detection of diabetic macular edema. Ophthalmology 1989; 96: 746-51.
Brancato R, Menchini U, Scialdone A, Bandello F. Focal versus scattered argon-green in diffuse macular edema: a prospective randomized trial. In: Gitter KA, Schatz H, Yannuzzi LA, Mc Donald HR, eds. San Francisco Pacific Medical Press, 1988: 69-73.
The Early Treatment of Diabetic Retinopathy Study Research Group. Treatment techniques and clinical guidelines for photocoagulation of diabetic macular edema. Ophthalmology 1987; 94: 761-74.
The Early Treatment of Diabetic Retinopathy Study Research Group. Techniques for scatter and focal photocoagulation. Int Ophthalmol Clin 1987; 27: 254-64.
Lee CM, Olk RJ. Modified grid laser photocoagulation for diffuse diabetic macular edema. Long-term visual results. Ophthalomology 1991; 98: 1594-602.
Casswell AG, Canning CR, Gregor ZJ. Treatment of diffuse diabetic macular edema: A comparison between argon and krypton lasers. Eye 1990; 4: 668-72.
Wallow IH, Repair of the pigment epithelial barrier following photocoagulation. Arch Ophthalmol 1984; 102: 126-35.
Marshall J, Glover G, Rothery S. Some new findings on retinal irradiation by krypton and argon lasers. Doc Ophthalmol Proc Ser 1984; 32: 21.
Wilson DJ, Finkelstein D, Quigley HA, Green WR. Macular grid photocoagulation. An experimental study on the primate retina. Arch Ophthalmol 1988; 106: 100-5.
About this article
Cite this article
Bandello, F., Lanzetta, P. & Menchini, U. When and how to do a grid laser for diabetic macular edema. Doc Ophthalmol 97, 415–419 (1999). https://doi.org/10.1023/A:1002499920673
- grid laser treatment
- diode laser